Some of pharma’s biggest players — including Merck, Amgen, Abbvie, and Gilead — formed an alliance to fight looming M&A reforms.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
The weight loss drug market could be worth $100 billion in the next few years. Naturally, other companies want in.
No matter how you cast your ballot in the presidential election last month, recent history suggests your vote counts for IPOs.
The offer would put an 83% premium on Soho’s Wednesday closing price and comes a year after it had to close off admissions in three cities.
One ring to rule them all… at least, Oura hopes so. On Thursday, it announced a new $200 million funding round.